CYBeR-CARE Announces Stern & Co. as Their New Media Partner.

BOYNTON BEACH, Fla.--(BW HealthWire)--Nov. 1, 1999--

CYBeR-CARE, Inc. (Nasdaq:CYBR) announced today that it has retained Stern & Co. to launch its investor and media relations campaign.

CYBeR-CARE, based in Boynton Beach, Fla., is a technology-assisted disease management company, which has developed a new Internet-based home monitoring system called the Electronic House Call System. The company also operates physical, occupational and speech therapy centers, pharmaceutical services and one of the world's largest international air ambulance transport service.

Michael Morrell, CEO, said: "We believe that our Electronic House Call System (EHC) will have a significant impact on improving patient care by enabling the patient to be in constant contact, physically and visibly, with a healthcare provider as well as lowering medical costs for chronically ill patients. With our proprietary system, medical practitioners can obtain vital medical information from the patient, such as blood pressure, temperature, ECG, on a real time basis."

The EHC has been successfully tested at the Mayo Clinic in Jacksonville, Fla., The Medical College of Georgia and the U.S. Army. CYBeR-CARE recently received a $2 million order for its EHC from Cambridge Medical Centers of Deerfield, Fla.

Stern & Co. is a rapidly growing New York City-based investor relations and corporate communications firm specializing in strategic counseling, financial and media relations, and crisis communications. Its clients include national and international financial services firms, Internet businesses, medical product and diagnostic tool developers, wireless communications companies and real estate investment trusts, among others.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: The statements which are not historical facts contained in this press release are forward-looking statements that involve certain risks and uncertainties including but not limited to risks associated with the uncertainty of future financial results, additional financing requirements, development of new products, government approval processes, the impact of competitive products or pricing, technological changes, the effect of economic conditions and other uncertainties detailed in the Company's filings with the Securities and Exchange Commission.